Farokhzad Omid
Farokhzad Omid's purchase track record
Farokhzad Omid has only 1 open-market purchase with a full 6 months of price history after it -- too few to call a track record yet.
| Purchase | Stock | Amount | 3 months | 6 months | S&P 500, 6 mo. |
|---|---|---|---|---|---|
| 8/23/2023 | SEER | $98K | -31.4% | -34.3% | +12.3% |
Computed by MarketWall from SEC Form 4 filings and daily closing prices (close on the purchase date to the close about 3 and 6 months later). Companies that have since delisted are not included. Past results, not investment advice.
Associated companies
Synthesized from recent news and fundamentals/technical data -- not human analyst commentary or trader sentiment.
October 2, 2026
SNTI Included in List of Health Care Stocks Moving Pre-Market. Senti Biosciences was named in a Benzinga report listing 12 health care stocks showing movement during Tuesday's pre-market session. The stock is currently trading within a wide 52-week range of $0.29 to $2.88. This inclusion highlights short-term trading activity rather than a specific fundamental change.
Transaction History
| SEER | ▼ Sell | Open Market | 24,385 | $49K | 2/18/2026 | View on chart |
| SEER | ▲ Buy | Grant | 697,162 | $0 | 2/3/2026 | View on chart |
| SEER | ▼ Sell | Other | 2,117,138 | — | 12/9/2025 | View on chart |
| SEER | ▼ Sell | Other | 1,438,057 | — | 12/9/2025 | View on chart |
| SEER | ▼ Sell | Open Market | 33,838 | $67K | 11/19/2025 | View on chart |
| SEER | ▼ Sell | Open Market | 33,992 | $69K | 8/20/2025 | View on chart |
| SEER | ▼ Sell | Open Market | 33,663 | $70K | 5/20/2025 | View on chart |
| SEER | ▼ Sell | Tax Withholding | 88,494 | $204K | 2/18/2025 | View on chart |
| SEER | ▼ Sell | Open Market | 8,068 | $18K | 2/4/2025 | View on chart |
| SEER | ▼ Sell | Open Market | 52,857 | $107K | 3/7/2024 | View on chart |
| SEER | ▲ Buy | Grant | 529,634 | $0 | 2/6/2024 | View on chart |
| SEER | ▲ Buy | Option Exercise | 151,764 | $6K | 11/2/2023 | View on chart |
| SEER | ▲ Buy | Open Market | 40,000 | $98K | 8/23/2023 | View on chart |
| SEER | ▼ Sell | Open Market | 13,840 | $57K | 2/21/2023 | View on chart |
| SEER | ▲ Buy | Grant | 402,000 | $0 | 2/15/2023 | View on chart |
| SEER | ▼ Sell | Open Market | 8,379 | $39K | 2/7/2023 | View on chart |
| SEER | ▼ Sell | Open Market | 4,800 | $25K | 1/17/2023 | View on chart |
| SEER | ▲ Buy | Option Exercise | 59,171 | $2K | 11/8/2022 | View on chart |
| SNTI | ▲ Buy | Option Exercise | 5,750,000 | $0 | 6/8/2022 | View on chart |
| SNTI | ▲ Buy | Grant | 250,000 | $2.5M | 6/8/2022 | View on chart |
| SNTI | ▼ Sell | Other | 4,518,097 | $0 | 6/8/2022 | View on chart |
| SEER | ▲ Buy | Grant | 155,000 | $0 | 2/8/2022 | View on chart |
AI Market Commentary
AI-generatedAll commentary →Synthesized from recent news and fundamentals/technical data -- not human analyst commentary or trader sentiment.
September 28, 2026
Seer to Present Proteomics Data at HUPO 2026; CFO Transition Announced
Seer Inc. will share early results from its PRECISE-SG100K proteomics study with Nanyang Technological University at the HUPO 2026 conference. The company also announced a transition in its Chief Financial Officer role. These developments provide updates on the firm's scientific progress and leadership structure.
Seer to Present Proteomics Data at HUPO 2026; CFO Transition Announced. Seer Inc. will share early results from its PRECISE-SG100K proteomics study with Nanyang Technological University at the HUPO 2026 conference. The company also announced a transition in its Chief Financial Officer role. These developments provide updates on the firm's scientific progress and leadership structure.